Tetracycline :: administration & dosage
Latest Paper:
Unity of Implantoplasty, Dental Clinic, University of Milan, San Paolo Hospital, Milan, Italy. eugenio.romeo@unimi.it
AIM: The aim of this study was to assess if the probing pocket depth is a reliable clinical parameter in the evaluation of the depth of the peri-implant sulci. In case of chronic inflamed peri-implant tissues, this evaluation is useful for understanding the level of bone resorption. METHODS: The study enrolled 22 patients. All of them were diagnosed for a peri-implantitis and were scheduled for a resective surgery with implantoplasty. During the surgery, a full thickness flap was raised and resective surgery was performed as well as an implantoplasty procedure. Peri-implant probing values before the surgery (PAL) were recorded, as were values of bone resorption after flap elevation (DIB), at all four sites around each implant (88 sites). RESULTS: The mean value of PAL calculated for all 88 sites was 5.67 mm (+/-1.46); the correspondent value of DIB was 6.37 mm (+/-1.81). In 52 sites out of 88 (59.1%) the values of PAL and DIB were exactly the same (maximum difference .5 mm). In only 10 cases (11.3%) the difference between PAL and DIB was >2 mm. The mean values for PAL and DIB were not statistically different. CONCLUSIONS: Authors have concluded that in case of chronic inflammation of peri-implant tissues, the probe reaches the bone pick, allowing the clinician to have reliable information on the actual bone resorption.
Mesh-terms: Alveolar Bone Loss :: diagnosis; Alveolar Bone Loss :: etiology; Alveolar Bone Loss :: surgery; Anti-Bacterial Agents :: administration & dosage; Anti-Bacterial Agents :: therapeutic use; Chronic Periodontitis :: diagnosis; Chronic Periodontitis :: etiology; Chronic Periodontitis :: surgery; Combined Modality Therapy; Debridement; Dental Implants :: adverse effects; Device Removal; Gels; Gingival Hemorrhage :: etiology; Humans; Metronidazole :: administration & dosage; Metronidazole :: therapeutic use; Periodontal Pocket :: diagnosis; Periodontal Pocket :: etiology; Periodontics :: instrumentation; Periodontics :: methods; Tetracycline :: administration & dosage; Tetracycline :: therapeutic use;
Most cited papers:
Forsyth Dental Center, Boston, MA 02115.
27 subjects with active destructive periodontal diseases were treated by modified Widman flap surgery and systemic tetracycline and divided into 4 groups based on pre- and post-therapy hazard rates (% of sites losing greater than 3 mm of attachment in 1 year). Pre- and post-therapy hazard rates were respectively: group I (3 subjects) less than 4 and less than 4; group II (8 subjects) greater than 4 and less than 4; group III (3 subjects) less than 4 and greater than 4; group IV (refractory group of 13 subjects) greater than 4 and greater than 4. Baseline mean pocket depths and attachment loss of groups I and II subjects were less than groups III and IV subjects and exhibited less suppuration. 6 group IV subjects lost a total of 38 teeth after therapy, in contrast to no tooth loss in subjects in the other 3 groups. Redness, bleeding on probing, plaque levels and age did not differ among groups. Subjects in the 4 groups differed in the subgingival species to which they showed elevated serum antibody responses. Group IV subjects showed elevated responses to a select range of gram-negative species, including A. actinomycetemcomitans strains Y4 or ATCC 29523, F. nucleatum and B. intermedius. No subject in any of the other groups exhibited an elevated response to B. intermedius. The mean % of each species in all sampled sites, both before and after therapy, was computed for each subject. Subjects in groups III and IV (high post-therapy hazard rates) exhibited elevated mean levels of B. forsythus, F. nucleatum, S. intermedius, E. corrodens, and B. gingivalis.(ABSTRACT TRUNCATED AT 250 WORDS)
Mesh-terms: Adolescent; Adult; Antibodies, Bacterial :: analysis; Bacteria :: immunology; Bacteria :: isolation & purification; Child; Combined Modality Therapy; Comparative Study; Dental Plaque :: immunology; Dental Plaque :: microbiology; Human; Middle Aged; Periodontal Diseases :: immunology; Periodontal Diseases :: microbiology; Periodontal Diseases :: therapy; Support, U.S. Gov't, P.H.S. ; Surgical Flaps; Tetracycline :: administration & dosage; Tetracycline :: therapeutic use;
Department of Medicine, Elisabeth Hospital, Academic Teaching Hospital, University of Essen, Germany.
Treatment with amoxicillin and omeprazole resulted in encouraging Helicobacter pylori eradication rates in pilot studies that included medium term follow up. These results were evaluated in a prospective, randomised and controlled study. Forty patients with active duodenal ulcer disease and H pylori colonisation of the gastric mucosa were randomly assigned to receive either omeprazole (20 mg twice daily) and amoxicillin suspension (500 mg four times daily) for two weeks (group I) or bismuth subsalicylate (600 mg three times daily), metronidazole (400 mg three times daily), tetracycline (500 mg three times daily), and ranitidine (300 mg in the evening) for two weeks (group II). Study medication was followed in both groups by a four week treatment course with 300 mg ranitidine up to the final examination. One patient from each group was lost to follow up. H pylori was eradicated in 78.9% of group I and 84.2% of group II (p = 1.00). All ulcers in patients on omeprazole plus amoxicillin healed but in the triple treatment group four patients had residual peptic lesions after six weeks (ulcer healing rate: 78.9%, p = .11). Complete pain relief occurred after a median duration of 1 day in group I and of 6 days in group II (p = .03). There were no major complications in either group but minor side effects were more frequently recorded in patients on triple therapy (63.2% v 15.8%, p < .01). In conclusion, two weeks of treatment with omeprazole plus amoxicillin is as good as triple therapy plus ranitidine in eradicating H pylori but seems better with regard to safety, pain relief, and ulcer healing. Thus, amoxicillin plus omeprazole should be recommended as the treatment of choice in eradicating H pylori in patients with duodenal ulcer disease.
Mesh-terms: Adult; Aged; Amoxicillin :: administration & dosage; Bismuth :: administration & dosage; Comparative Study; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections :: drug therapy; Helicobacter pylori; Human; Male; Metronidazole :: administration & dosage; Middle Aged; Omeprazole :: administration & dosage; Organometallic Compounds :: administration & dosage; Prospective Studies; Salicylates :: administration & dosage; Tetracycline :: administration & dosage;
The purpose of this study was to compare the efficacy of scaling and root planing (S and RP) alone versus tetracycline fiber therapy used adjunctively with S and RP in the treatment of localized recurrent periodontitis sites in maintenance patients. A total of 113 patients receiving regular supportive periodontal therapy (SPT) were treated with whole mouth S and RP. Two non-adjacent sites in separate quadrants were selected in each patient for monitoring based on criteria that the sites were 5 to 8 mm deep and had a history of bleeding on probing. The chosen sites were randomly assigned to one of the two treatment groups. Probing depth (PD), bleeding on probing (BOP), and clinical attachment level (CAL) were measured at baseline and 1, 3, and 6 months. At 1, 3 and 6 months, adjunctive fiber therapy was significantly better in reducing PD (P < .05) and reducing BOP (P < .05) than S and RP alone. At 6 months, fiber therapy was significantly better in promoting clinical attachment gain (P < .05) than S and RP alone. Overall, these results indicate that fiber therapy significantly enhanced the effectiveness of S and RP in the management of localized recurrent periodontitis sites, in patients receiving regular supportive periodontal treatment.
Mesh-terms: Arizona; Colorado; Connecticut; Delayed-Action Preparations; Dental Scaling; Female; Human; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Periodontal Index; Periodontitis :: drug therapy; Periodontitis :: therapy; Root Planing; Support, Non-U.S. Gov't; Tetracycline :: administration & dosage; Tetracycline :: therapeutic use; Texas; Treatment Outcome; Wisconsin;
J M Goodson,
M A Cugini,
R L Kent,
G C Armitage,
C M Cobb,
D Fine,
M E Fritz,
E Green,
M J Imoberdorf,
W J Killoy
Forsyth Dental Center, Boston, MA.
The safety and efficacy of periodontal disease treatment by intrapocket placement of tetracycline (TC) fibers was investigated in a 60-day multicenter study conducted by selecting 4 sites in each subject with 6-10 mm pockets that bled on probing. Sites were randomly assigned to 1 of 4 test groups: TC fiber therapy, scaling, control fiber (fibers without drug), or untreated. TC fibers and control fibers were placed to fill the pocket and were maintained with a cyanoacrylate adhesive for 10(+/- 2) d. Scaling was performed for a minimum of 5 min under local anesthesia. Following initial tooth cleaning procedures, pocket depth, attachment level and bleeding on controlled-force probing were measured at baseline and at 30 d, and 60 d following therapy. Analysis of data from 107 subjects who had complete clinical data sets indicated that TC fiber therapy significantly decreased pocket depth, increased attachment level, and decreased bleeding on controlled-force probing to a greater extent than observed in all other test groups including scaling. These effects were greater than, and in addition to, effects that occurred due to prophylaxis and improved home care. No serious adverse side-effects attributed to TC fiber therapy were observed. No TC fiber-treated sites abscessed and superinfection was not noted. A transient redness at fiber removal was seen at 21% of the sites. Although fibers were placed without anesthesia, mild pain on initial placement was infrequent (19%) and abated rapidly. The results indicate that TC fiber placement provides a safe and effective means for treatment of periodontal infections.
Mesh-terms: Adult; Analysis of Variance; Chi-Square Distribution; Epithelial Attachment :: pathology; Female; Human; Least-Squares Analysis; Linear Models; Male; Middle Aged; Periodontal Diseases :: drug therapy; Periodontal Index; Periodontal Pocket :: drug therapy; Periodontal Pocket :: pathology; Random Allocation; Support, Non-U.S. Gov't; Tetracycline :: administration & dosage;
Mesh-terms: Administration, Topical; Bacteria :: cytology; Bacteria :: drug effects; Dental Plaque :: pathology; Dosage Forms; Gingiva :: pathology; Humans; Periodontal Index; Periodontal Pocket :: microbiology; Periodontitis :: drug therapy; Periodontitis :: surgery; Subgingival Curettage; Tetracycline :: administration & dosage; Tetracycline :: pharmacology;
Department of Periodontology, University of Helsinki, Finland.
Systemic metronidazole and tetracycline were compared as adjunctive agents in the treatment of localized juvenile periodontitis (LJP). 27 patients with Actinobacillus actinomycetemcomitans-positive (Aa) LJP were treated with scaling and rootplaning, control of oral hygiene and periodontal surgery if indicated. The patients were randomly divided into 3 equal groups: the 1st group had metronidazole 200 mg x 3 x 10 days, the 2nd tetracycline 250 mg x 4 x 12 days, the 3rd group received no medication and served as a control. 6 patients had periodontal surgery. 4 sites with the most advanced bone loss as determined on radiographs were selected in each subject for test sites. Gingival index, gingival bleeding after probing (GB), probing depth (PD), suppuration, and radiographic bone loss were registered, and subgingival Aa was selectively cultured. GB and PD > or = 4 mm were registered in the whole dentition as well. All parameters were monitored at baseline and at 6 and 18 months after treatment. By the end of the study, Aa was suppressed to below detection level at all test sites only in the metronidazole group, at 17/26 sites (4 patients) in the tetracycline group and at 19/26 sites (6 patients) in the control group. Clinically, all groups showed improvement. In conclusion, metronidazole was more effective than tetracycline in the suppression of Aa and the suppression of Aa appeared to produce better clinical results.
Mesh-terms: Actinobacillus actinomycetemcomitans :: drug effects; Actinobacillus actinomycetemcomitans :: isolation & purification; Adolescent; Adult; Alveolar Bone Loss :: prevention & control; Alveolar Bone Loss :: radiography; Comparative Study; Dental Plaque :: microbiology; Female; Gingival Hemorrhage :: microbiology; Gingival Hemorrhage :: pathology; Gingival Hemorrhage :: prevention & control; Human; Male; Metronidazole :: administration & dosage; Metronidazole :: therapeutic use; Periodontal Index; Periodontal Pocket :: microbiology; Periodontal Pocket :: pathology; Periodontal Pocket :: prevention & control; Periodontitis, Juvenile :: drug therapy; Periodontitis, Juvenile :: microbiology; Periodontitis, Juvenile :: radiography; Periodontitis, Juvenile :: surgery; Support, Non-U.S. Gov't; Tetracycline :: administration & dosage; Tetracycline :: therapeutic use;
This study reports on the development of drug containing acrylic strips for delivering antimicrobial agents and compares the in vitro release pattern with dialysis tubing. Polyethylmethacrylic strips of suitable dimensions containing 10 to 50% chlorhexidine acetate, 40% metronidazole and 40% tetracycline were prepared. Daily release of the incorporated drugs into 1 ml aliquots was measured spectrophotometrically over a 14 day period. Similarly the release of chlorhexidine gluconate from various lengths of patent and heat sealed dialysis tubing was recorded for 4 days. At 30%, 40% and 50% admixtures the acrylic strips released chlorhexidine up to the 14 day period and a parallel bioassay confirmed the maintenance of antibacterial activity to this time. At the same admixture the release of metronidazole was greater than chlorhexidine and tetracycline. All drugs were released at high levels on day 1 followed by a marked fall in release by day 2 and progressive fall thereafter. The release from tubing was almost total within 24 hours and was independent of sealing the ends. The strips appear to have potential for prolonged drug delivery to periodontal pockets. Preliminary clinical use revealed no patient acceptability problems and alterations in subgingival flora were produced.
Mesh-terms: Chlorhexidine :: administration & dosage; Comparative Study; Delayed-Action Preparations; Dialysis :: instrumentation; Dosage Forms; Human; Intubation :: instrumentation; Methylmethacrylates; Metronidazole :: administration & dosage; Periodontal Pocket :: drug therapy; Spectrophotometry; Tetracycline :: administration & dosage;
Mesh-terms: Administration, Oral; Age Factors; Child; Demeclocycline :: administration & dosage; Demeclocycline :: adverse effects; Female; Human; Incisor; Male; Tetracycline :: administration & dosage; Tetracycline :: adverse effects; Time Factors; Tooth Calcification :: drug effects; Tooth Discoloration :: chemically induced;
Mesh-terms: Acidosis :: prevention & control; Administration, Oral; Adolescent; Adult; Aged; Bangladesh; Bicarbonates :: administration & dosage; Child; Child, Preschool; Cholera :: drug therapy; Cholera :: mortality; Cholera :: prevention & control; Dehydration :: prevention & control; Diarrhea :: drug therapy; Female; Glucose :: administration & dosage; Human; Infant; Injections, Intravenous; Male; Middle Aged; Refugees; Sodium Chloride :: administration & dosage; Solutions; Tetracycline :: administration & dosage; Vomiting :: prevention & control; Water-Electrolyte Balance;
Department of Periodontology, Catholic University of Leuven, Belgium.
The recognition of the microbial origin and the specificity of periodontal infections has resulted in the development of several adjunctive therapies (antibiotics and/or antiseptics) to scaling and root planing in the treatment of chronic adult periodontitis. This article aims to review the "additional" effect of a subgingival irrigation with chlorhexidine, or a local or systemic application of tetracycline or metronidazole, performed in combination with a single course of scaling and root planing in patients with chronic adult periodontitis. All treatment modalities are compared with scaling and root planing, based on their impact on: the probing depth (PD); total number of colony forming units per ml (CFU/ml); the proportions and/or the detection-frequency of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia; and/or on the percentages of cocci, spirochetes, motile, and other micro-organisms on dark field microscopy examination. All treatment modalities, including scaling and root planing without additional chemical therapy, resulted in significant reductions in the probing depth and the proportions of periodontopathogens, at least during the first 8 weeks post-therapy. However in comparison to a single course of scaling and root planing, the supplementary effect of adjunctive therapies seems to be limited. In general, only the irrigation with chlorhexidine 2%, the local application of minocycline, and the systemic use of metronidazole (in case of large proportions of spirochetes) or doxycycline (in case of large proportions of A. actinomycetemcomitans) seem to result in a prolonged supplementary effect when compared to scaling and root planing. Therefore, the use of antibiotics on a routine basis, especially in a systemic way, in the treatment of chronic adult periodontitis, can no longer be advocated, considering the increasing danger for the development of microbial resistance.
Mesh-terms: Actinobacillus actinomycetemcomitans :: drug effects; Actinobacillus actinomycetemcomitans :: isolation & purification; Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents :: administration & dosage; Anti-Infective Agents, Local :: administration & dosage; Antitrichomonal Agents :: administration & dosage; Chemotherapy, Adjuvant; Chlorhexidine :: administration & dosage; Chronic Disease; Colony Count, Microbial; Dental Scaling; Gels; Human; Irrigation; Metronidazole :: administration & dosage; Periodontitis :: microbiology; Periodontitis :: therapy; Porphyromonas gingivalis :: drug effects; Porphyromonas gingivalis :: isolation & purification; Prevotella intermedia :: drug effects; Prevotella intermedia :: isolation & purification; Root Planing; Spirochaetales :: drug effects; Spirochaetales :: isolation & purification; Tetracycline :: administration & dosage;
